Mon.Oct 02, 2023

article thumbnail

Nobel Prize Awarded to Scientists Whose mRNA Work Allowed Development of COVID-19 Vaccines

Drug Topics

Katalin Karikó, PhD, and Drew Weissman, MD, PhD, were cited "for their discoveries concerning nucleoside base modifications that enabled the development of effective mRNA vaccines against COVID-19.

Vaccines 503
article thumbnail

The ALS therapy keeping the human pig heart transplant pumping

PharmaVoice

Eledon’s investigational ALS drug tegoprubart could also help prevent organ transplant rejections, the company says.

321
321
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Novel Self-Amplifying mRNA Vaccine Demonstrates Robust, Durable Immune Response

Drug Topics

Vaccines were tested against various strains of the SARS-CoV-2 virus.

Vaccines 281
article thumbnail

5 FDA decisions to watch in the fourth quarter

PharmaVoice

The regulator is considering approval of what would be the first CRISPR medicine, as well as important clearances for Alnylam, Bristol Myers, Amgen and Pfizer.

FDA 246
article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

How Pharmacies Can Prepare for the 2024 DIR Fee Changes

Drug Topics

In a webinar hosted by the National Community Pharmacists Association, experts from accounting agency Sykes & Company, PA discussed how pharmacies can navigate the upcoming changes.

281
281
article thumbnail

American Pharmacists Month: Recognizing the Vital Role and Professional Challenges

Pharmacy Times

The origins of American Pharmacists Month trace back to October 1925, when radio stations nationwide aired special programming for a week to spotlight the pharmacy profession.

153
153

More Trending

article thumbnail

Expanding How to Assess Adherence in Older Adults With Home Medication Management

Pharmacy Times

“There is method to this madness” describes routines that affect adherence to medication regimens.

153
153
article thumbnail

Adalimumab Biosimilar Now Available at Significant Discount to Humira

Drug Topics

Boehringer Ingelheim’s unbranded adalimumab-adbm biosimilar will be available at an 81% discount to adalimumab (Humira).

247
247
article thumbnail

Celebrating Pharmacists This October

Pharmacy Times

Craig Dolan, PharmD, MBA, BSPharm discusses the role of the pharmacist, how the pharmacy profession has changed, and what is to come in the field.

145
145
article thumbnail

Implementing a Year-Long Vaccine Program Helps Community Pharmacies Increase Profits

Drug Topics

By offering vaccines year-round instead of only during the typical flu season, community pharmacies can maximize profits and help patients live healthier lives.

article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

Cigna to pay $172M to settle claims it overcharged Medicare Advantage program

Fierce Healthcare

Cigna will pay $172 million to settle allegations brought by a whistleblower and the U.S. | Cigna will pay $172 million to settle allegations brought by the U.S. government that it submitted false and inaccurate Medicare Advantage diagnostic codes in a bid to boost its reimbursement.

140
140
article thumbnail

NDA for Investigational Schizophrenia Treatment Submitted to FDA

Drug Topics

The NDA was submitted for investigational muscarinic antipsychotic, KarXT (xanomeline-trospium), which functions as a dual M1/M4 muscarinic acetylcholine receptor agonist within the central nervous system.

FDA 247
article thumbnail

Digital health investments shift to disease treatment, workflow solutions and VBC in Q3: Rock Health

Fierce Healthcare

Digital health founders and investors continue to face a tighter funding cycle with fewer deals and lower check sizes. | In Q3 2023, U.S. digital health startups raised $2.5 billion across 119 deals, the second-lowest quarter by funding total since the fourth quarter of 2019, Rock Health reports.

140
140
article thumbnail

Can the world still invent an HIV vaccine? Progress in one area creates new problem

STAT

Louis Picker is nervous. Last month, the first volunteer was injected with an HIV vaccine he spent over 20 years designing. It’s prototype No. 2. The last shot they tested, in 2021, didn’t do much of anything, and the 66-year-old worries that if this fails, he might not get another chance to redesign it.  Truthfully, though, Picker isn’t sure his HIV vaccine stands much of a chance.

Vaccines 139
article thumbnail

What the FDA's New Dosage Guidance Means for the Future of Clinical Research

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

article thumbnail

FDA Approves Nedosiran for Patients With Primary Hyperoxaluria Type 1

Pharmacy Times

Nedosiran (Rivfloza; Novo Nordisk Inc) injection is designed to inhibit the expression of liver enzyme lactate dehydrogenases leading to oxalate overproduction in patients 9 years of age and older with PH1.

FDA 139
article thumbnail

The stability of $0 premiums in Medicare Advantage

STAT

You’re reading the web edition of Health Care Inc., STAT’s weekly newsletter following the flow of money through the health care system.  Sign up here  to get it in your inbox. Arbitration, the land where nobody is happy After Congress officially outlawed most types of surprise medical bills last year, there’s been endless, litigious debate as to how health insurance companies and providers should settle their differences while patients are held harmless.

article thumbnail

Pharmacy Focus: Policy Edition - Navigating Provider Status: Challenges, Implications, and Advocacy in Pharmacy

Pharmacy Times

Tune in to this enlightening episode of Pharmacy Focus: Policy Edition to gain a deep understanding of the challenges, implications, and advocacy strategies surrounding provider status for pharmacists.

132
132
article thumbnail

WHO recommends second malaria vaccine, hoping to address supply issues

STAT

Just two years after the World Health Organization’s historic recommendation of the first malaria vaccine, the global health agency on Monday recommended a second , seeking to broaden access to a tool it hopes can save lives. The vaccine, called R21/Matrix-M, was developed by the University of Oxford and will be produced by the Serum Institute of India, the world’s largest vaccine manufacturer.

Vaccines 132
article thumbnail

5 Reasons to Upgrade Your Pharmacy Management Software

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

article thumbnail

The PharmaVoice 100: Cancer care visionaries

PharmaVoice

Leaders shaping the future of oncology and cancer care through grit and determination in the face of one of healthcare’s greatest challenges.

130
130
article thumbnail

STAT+: Verily lands $38 million deal with CDC for wastewater surveillance

STAT

Alphabet’s life sciences company Verily has scored its first Centers for Disease Control and Prevention contract, a high profile job leaders hope will boost its brand in public health as well as its nascent wastewater surveillance business, executives told STAT. Under the up-to-five year, $38 million contract, Verily will collect samples from hundreds of wastewater treatment centers across the country, analyze them for Covid-19 and the mpox virus at its South San Francisco lab, and return

129
129
article thumbnail

Harnessing Technology to Boost Medication Access

Pharmacy Times

Better access to prescription drugs improves patients’ experience, adherence, and health.

123
123
article thumbnail

Report: CMMI has raised federal spending, not lowered it

Fierce Healthcare

The Center for Medicare and Medicaid Innovation (CMMI), once expected to save money and deliver healthcare at a lower cost, is increasing federal spending after all. | CMMI was designed to reduce federal healthcare spending, but a new CBO reports shows its had the opposite effect. Some say this is the necessary outcome of embracing value-based care.

122
122
article thumbnail

Intravenous Immunoglobulin Reduces Risk of Severe Infection When Used with BCMA Bispecific Antibody for Multiple Myeloma

Pharmacy Times

Intravenous immunoglobulin could potentially be given throughout the duration of anti-BCMA bispecific antibody therapy for the treatment of multiple myeloma.

120
120
article thumbnail

STAT+: Former FDA official lays out how to keep patients safe from risky medical devices

STAT

Madris Kinard’s unlikely journey to becoming a champion for patient safety started in a fire station. As a fresh-faced college intern for a company insuring volunteer firefighters, she asked one of the firefighters if she could do something on every child’s bucket list: slide down the fire pole. “They were like, you work for our insurance company,” Kinard said.

Insurance 120
article thumbnail

Enhancing pharma brand performance through in-depth customer engagement insights

pharmaphorum

Enhancing pharma brand performance through in-depth customer engagement insights Mike.

119
119
article thumbnail

STAT+: New lawsuit highlights another wrinkle for settling disputes over surprise medical bills

STAT

After Congress officially outlawed surprise medical bills last year, there’s been endless, litigious debate as to how health insurance companies and providers should settle their differences over how much to pay for out-of-network medical bills. Now, an air ambulance provider that already went through the arbitration process is suing Blue Cross Blue Shield of Arizona, which the company says won’t pay the agreed-upon amounts.

article thumbnail

Taking a page from consumer-facing tech, Providence launches startup to modernize patient engagement

Fierce Healthcare

Renton, Washington-based Providence launched a new startup to modernize patients' digital experience with the traditional healthcare system. | Health systems must take a page from the book of other consumer-facing industries, said Sara Vaezy, chief strategy and digital officer at Providence. The health system launched Praia Health to modernize patients' experience with the traditional healthcare system.

118
118
article thumbnail

Bracing for rough respiratory virus season, European officials urge vaccination

STAT

LONDON — Health officials in the U.K. and Europe are ramping up their campaigns urging eligible people to get another vaccine round against Covid and flu, promoting the immunizations as people’s best way to protect themselves and reduce pressure on health systems during what is expected to be another tough winter. In the 2022-2023 season, parts of Europe endured early and severe waves of respiratory viruses and consequently suffered drug shortages, with a particular crunch on medic

Vaccines 117
article thumbnail

Dollar General opens first Montana store

Drug Store News

With the addition of the Columbia Falls store in Montana, Dollar General now serves all 48 continental U.S. states.

116
116
article thumbnail

STAT+: Congress extends some pandemic preparedness programs, but not all

STAT

WASHINGTON — Congress temporarily extended a few pandemic-preparedness programs when it forestalled a government shutdown at the last minute Saturday evening. But a program that encourages the development of countermeasures for big public health problems like pandemics expired without reauthorization. With hours left before a funding lapse, Congress passed a measure to keep the government running for another 45 days.

116
116
article thumbnail

Navigating Health Insurance Coverage for Innovative and Specialty Drugs: Q&A With Maria Kirsch, President of Patients Services at EVERSANA

PharmExec

Kirsch discusses the complexity of the drugs and the verification process, along with EVERSANA’s new platform, ACTICS eAccess.

article thumbnail

Opinion: The new fertility technology IVG is supposed to change everything. Don’t count on it yet

STAT

There are times when a new medical technology is thrust into the public spotlight because it seems like it might solve what we thought was unsolvable. Not for the first time, this is being played out in the field of reproductive technology with in vitro gametogenesis, or IVG. It’s been hailed as revolutionary technology that will be life-altering for those with infertility.

113
113
article thumbnail

Independence Blue Cross touts enhanced Medicare Advantage offerings for 2024

Fierce Healthcare

Independence Blue Cross unveiled Medicare Advantage (MA) packages that the company said will greatly enhance benefits for its MA members, including a bigger allowance for vision, dental, hearing an | The MA enhancements touted by Independence Blue Cross include reducing premiums for its Personal Choice 65 PPO while including a Part B giveback and a bigger allowance for vision, dental, hearing and over-the-counter items.

Packaging 112